Caption Management’s SpringWorks Therapeutics SWTX Stock Holding History

Caption Management’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-116,994	Closed	-$5.2M	–	1874
2025 Q1	$5.16M	Buy	+116,994	New	+$5.39M	0.05%	382
2024 Q2	–	Sell	-4,000	Closed	-$197K	–	1488
2024 Q1	$197K	Buy	+4,000	New	+$185K	﹤0.01%	1005
2022 Q3	–	Sell	-1,993	Closed	-$57.1K	–	1830
2022 Q2	$49K	Sell	1,993 -23,187	-92%	-$848K	﹤0.01%	1340
2022 Q1	$1.42M	Buy	+25,180	New	+$1.44M	0.02%	854

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Caption Management's SWTX Position: Q2 2025 in Review

Caption Management sold out of SpringWorks Therapeutics (SWTX) in Q2 2025, closing a stake of 116,994 shares — an estimated $5.2M sold.

Caption Management first reported a position in SWTX in Q1 2022 and held it in 4 quarters. The position peaked at $5.16M in Q1 2025. 223 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.

Caption Management reported no remaining SpringWorks Therapeutics position as of Q2 2025 after selling out during the quarter.
Caption Management sold 116,994 SpringWorks Therapeutics shares in Q2 2025, an estimated $5.2M.
Caption Management first reported a position in SpringWorks Therapeutics in Q1 2022 and held it in 4 quarters.
Caption Management's SpringWorks Therapeutics position peaked at $5.16M in Q1 2025.
223 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.

Based on Caption Management's 13F filing for Q2 2025, filed 14 Aug 2025.